a leading digital provider of resources and information to oncology
professionals, announces the State of the Science Summit™: Breast
Cancer. The event will take place on Oct. 11, at the JW Marriott San
Francisco Union Square in San Francisco. The conference will be chaired
by Hope S. Rugo, M.D., clinical professor, department of medicine
(hematology/oncology), director, breast oncology, clinical trials
program, University of California, San Francisco.
This three-and-a-half-hour educational event is designed to discuss some
of the most pressing topics in breast cancer, including genomic testing
in early- and late-state disease, advanced HER2-positive breast cancer
and triple-negative breast cancer. The summit will feature the following
prominent medical professionals from University of California, San
A. Jo Chien, M.D.
Melanie Majure, M.D.
Michelle Melisko, M.D.
Laura van ‘t Veer, Ph.D.
State of the Science Summit™ is a premier conference series hosted by
OncLive® with medical experts from across the nation. Aiming to discuss
the current treatment options, the summit integrates academic and
community-based physicians and health care professionals across key
disciplines that range from medical and surgical oncology and hematology.
To secure a seat and to get more information, please visit www.onclive.com/meetings/soss
or contact Allison Cooper at: ACooper@curetoday.com.
A digital platform of resources for practicing oncologists, OncLive.com
offers oncology professionals information they can utilize to help
provide the best patient care. OncLive® is the official website for
Michael J. Hennessy Associates’ Oncology Specialty Group, which
publishes OncologyLive®, Oncology Nursing News®, Oncology
Business Management™ and more. Michael J. Hennessy Associates, Inc.
is a full-service health care communications company offering education,
research, medical media, including curetoday.com and CURE®
magazine, the largest U.S. consumer publication focused entirely on
cancer. Combining science and humanity to make cancer understandable, CURE®
reaches patients, cancer centers and advocacy groups.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171009005098/en/